Clinical Trial Update: Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of colony-stimulating factors to relieve neutropenia in patients with recurrent non-Hodgkin's lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma, Neutropenia | Phase 2 | Status: COMPLETED